Nov 26 2010
Segasist Technologies, a Canadian software company developing contouring productivity tools for medical imaging, has today announced the receipt of funding from The Health Technology Exchange (HTX) towards support of clinical validation of its software, to be conducted at the Lawson Health Research Institute and London Health Sciences Centre (London, Ontario). Experts from Sunnybrook Research Institute and Sunnybrook Health Sciences Centre will also participate in the validation process by providing input in the form of gold standard contours.
Segasist PMR-R is a software tool developed for the purpose of processing Magnetic Resonance Images (MRI) of the prostate. Version 1.0, released on May 17, 2010, was created to assist researchers presently developing a role for MRI in diagnosis, tracking and treatment of prostate cancer. Version 1.1 released on August 24, 2010, following extensive internal validation, continues to assist prostate MRI researchers with a variety of improvements to the previous version. Segasist Technologies will be releasing version 2.0 of the software at RSNA 2010.
The funding received from HTX will augment grants from other sources to enable a pre-calibrated version of Segasist PMR-R to be validated with the ultimate goal of releasing Segasist PMR-C for clinical use following regulatory approval.
"The purpose of the validation process will be to show that the Segasist PMR platform offers significant time savings for clinicians performing image segmentation and volume calculations, as well as a high level of semi-automated contouring accuracy" explains Hamid Tizhoosh, CEO of Segasist Technologies, "Segasist PMR is the first commercial software of its kind providing a complete solution for segmentation and volumetric measurements of the prostate gland in MR images."
Associations between food additive emulsifiers and cancer risk